Praise for PBS expanded listing

More Australian adults can now access subsidised ADHD medication Vyvanse (lisdexamfetamine) From today (1 Feb), the Government has expanded the listing of Vyvanse (lisdexamfetamine) to include patients who are diagnosed with ADHD after they turn 18 years old. Prior to this, Vyvanse was only subsidised for Australians who were diagnosed as children, with those diagnosed